Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review

Region:Europe

Author(s):

Product Code:GDPH28215SA

Download Sample Report download
Buy the Full ReportStarting from $125
Published on

October 2019

Total pages

33

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $125

About the Report

About the Report

Chiesi Farmaceutici SpA-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

Chiesi Farmaceutici SpA (Chiesi) researches, develops, produces and commercializes novel medicines with focus on respiratory, neonatology, rare disease and special care therapeutic areas. The company provides products for the treatment of chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis, ankylosing spondylitis, hypertension, percutaneous coronary intervention, apnoea of prematurity, respiratory distress syndrome (RDS), lipoprotein lipase deficiency (LPLD), limbal stem cell deficiency (LSCD), inflammatory bowel diseases and renal and liver failure-solid organ transplant (SOT). The company operates production sites in Parma, Italy; Blois, France; and Santana De Parnaiba, Brazil; and conducts research and development activities at its new R&D center in Parma and at laboratories in Paris, Chippenham (UK), Cary (US), Lidingo (Sweden) and Hillerod (Denmark). Chiesi is headquartered in Parma, Italy.

Chiesi Farmaceutici SpA Key Recent Developments

Aug 05,2019: Santhera licences Leber's hereditary optic neuropathy drug to Chiesi

Jul 09,2019: Chiesi Group confirms positive trend to date for 2019

Jun 06,2019: Chiesi Group is the largest pharmaceutical group in the world to be awarded B Corp certification

Jul 31,2018: Inhalation Sciences in 3-year research project with 5 organizations, including purchase of new PreciseInhale system by Chiesi

Mar 27,2018: Construction Launch For New Chiesi Farmaceutici Headquarters

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Products

Products

Chiesi Farmaceutici SpA, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Zambon Italia Srl

SIFI SpA

Siena Biotech SpA

Recordati SpA

Newron Pharmaceuticals SpA

FB Health SpA

Cosmo Pharmaceuticals NV

Table of Contents

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Chiesi Farmaceutici SpA-Key Facts

Chiesi Farmaceutici SpA-Key Employees

Chiesi Farmaceutici SpA-Major Products and Services

Chiesi Farmaceutici SpA-History

Chiesi Farmaceutici SpA-Company Statement

Chiesi Farmaceutici SpA-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Chiesi Farmaceutici SpA-Business Description

Chiesi Farmaceutici SpA-Corporate Strategy

Chiesi Farmaceutici SpA-SWOT Analysis

SWOT Analysis-Overview

Chiesi Farmaceutici SpA-Strengths

Chiesi Farmaceutici SpA-Weaknesses

Chiesi Farmaceutici SpA-Opportunities

Chiesi Farmaceutici SpA-Threats

Chiesi Farmaceutici SpA-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Chiesi Farmaceutici SpA, Recent Deals Summary

Section 4-Company's Recent Developments

Aug 05, 2019: Santhera licences Leber's hereditary optic neuropathy drug to Chiesi

Jul 09, 2019: Chiesi Group confirms positive trend to date for 2019

Jun 06, 2019: Chiesi Group is the largest pharmaceutical group in the world to be awarded B Corp certification

Jul 31, 2018: Inhalation Sciences in 3-year research project with 5 organizations, including purchase of new PreciseInhale system by Chiesi

Mar 27, 2018: Construction Launch For New Chiesi Farmaceutici Headquarters

Feb 05, 2018: Amiko receives CE mark for three novel inhaler sensors

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List of Figure

List of Figures

Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List of Table

List of Tables

Chiesi Farmaceutici SpA, Key Facts

Chiesi Farmaceutici SpA, Key Employees

Chiesi Farmaceutici SpA, Major Products and Services

Chiesi Farmaceutici SpA, History

Chiesi Farmaceutici SpA, Subsidiaries

Chiesi Farmaceutici SpA, Key Competitors

Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Chiesi Farmaceutici SpA, Recent Deals Summary

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022